Meningeal Carcinomatosis — Trials

Meningeal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: Guangzhou Medical University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 51–59 of 59 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04148898	Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis(OWONBNSCLCLM)	unknown	Phase 2	80	Second Affiliated Hospital of Nanchang UniversityOTHER	0	Nov 4, 2019	clinicaltrials
NCT03082144	Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors	completed	Phase 2	53	The First Hospital of Jilin UniversityOTHER	1